PRP Versus Tranexamic Acid mesoneedling in Melasma Treatment
Phase 1
Recruiting
- Conditions
- Melasma.Other disorders of pigmentation
- Registration Number
- IRCT20200127046282N12
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
People with melasma on the cheeks and other areas of the face
Exclusion Criteria
Any complication that is related to the treatment process or is not tolerated by the patient
The patient does not want to continue treatment for any reason
Cancers, pregnancy, lactation, DVT, pulmonary embolism, stroke
Incidence of drug allergies
Occurrence of hypertrophic or colloidal scars at the treatment site
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melasma area recovery rate. Timepoint: Before treatment and 1 month after the last session. Method of measurement: Visioface.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: 1 months after the last session. Method of measurement: Questionnaire and visit.